Concepedia

Bibliometric and visual analysis in the field of tea in cancer from 2013 to 2023

Yuanchu Lian, Xiating Li, Ying Lan, Zonghuai Li, Xiaoxin Lin, Jing’an Huang, Bo Zhang, Zhongwen Feng

Frontiers in Oncology · 2024 · 11 citations · 19 references

DOIFull text

Open access

Abstract

Tea's potential as an anti-cancer medication is gaining global recognition. Our study provides a comprehensive analysis of tea-related cancer research from 2013 to 2023, guiding future investigations in this field.

References

19

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2021 · 109.5K citations · Full text

The ever‐increasing importance of cancer as a leading cause of premature death worldwide

Freddie Bray, Mathieu Laversanne, Elisabete Weiderpass et al. · Cancer · 2021 · 2.4K citations · Full text

, , +20

First-Line Immunotherapy for Non–Small-Cell Lung Cancer

Journal of Clinical Oncology · 2022 · 801 citations

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

, , +7

Global Evolution of Research in Artificial Intelligence in Health and Medicine: A Bibliometric Study

Bach Xuan Tran, Giang Thu Vu, Giang Hai Ha et al. · Journal of Clinical Medicine · 2019 · 439 citations · Full text

, , +24